维宏股份 reported revenue of ¥0.29B for the period ended 2026-06-30, +10.1% year on year. Net income was ¥0.01B, a 2.0% net margin on a 48.6% gross margin. The largest revenue line is 一体机 at 57% of the total. Free cash flow for the period was ¥0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.29B | +10.1% |
| Gross profit | ¥0.14B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | -80.2% |
| Gross margin | 48.6% | Net margin 2.0% |
| Revenue Q/Q | +44.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 一体机 | ¥0.16B | 57.2% |
| 控制卡 | ¥0.06B | 20.1% |
| 驱动器 | ¥0.04B | 14.1% |
| 其他主营业务 | ¥0.02B | 6.5% |
| 其他(补充) | ¥0.01B | 2.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.15B | 51.4% |
| R&D | ¥0.06B | 20.3% |
| SG&A | ¥0.06B | 21.4% |
| Tax & other | ¥0.00B | 0.3% |
| Item | Amount |
|---|---|
| Total assets | ¥1.07B |
| Total liabilities | ¥0.20B |
| Shareholders' equity | ¥0.87B |
| Equity / assets | 81.0% |
| Operating cash flow | ¥0.02B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.02B |
| Cash conversion (OCF / net income) | 398% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
新美星 ・ 金冠股份 ・ 雪榕生物 ・ 中亚股份 ・ 恒实科技 ・ 友讯达 ・ 三德科技 ・ 久之洋 ・ 海波重科 ・ 新迅达 ・ 新光药业 ・ 科大国创
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies